Naibin Yang

1.6k total citations
39 papers, 1.0k citations indexed

About

Naibin Yang is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Naibin Yang has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Hepatology. Recurrent topics in Naibin Yang's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Naibin Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Naibin Yang collaborates with scholars based in China, United States and Brazil. Naibin Yang's co-authors include Guoqing Qian, Ada Ma, Mingqin Lu, Jinguo Chu, Guoxiang Li, Liping Wang, Xueqin Chen, Xiaohong Chen, Guoxiang Li and Chunli Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Naibin Yang

38 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naibin Yang China 13 449 189 189 173 139 39 1.0k
Junke Long China 7 372 0.8× 205 1.1× 178 0.9× 145 0.8× 93 0.7× 9 997
Mingxing Huang China 14 308 0.7× 175 0.9× 197 1.0× 108 0.6× 103 0.7× 60 875
Kamran Baig United Kingdom 16 743 1.7× 111 0.6× 239 1.3× 282 1.6× 94 0.7× 51 1.5k
Haibin Wang China 8 678 1.5× 170 0.9× 135 0.7× 241 1.4× 100 0.7× 16 1.1k
Zhen Chen China 17 822 1.8× 184 1.0× 160 0.8× 86 0.5× 97 0.7× 58 1.8k
Fangqiang Wei China 11 555 1.2× 281 1.5× 84 0.4× 180 1.0× 216 1.6× 32 1.4k
Yi‐Chang Cheng Taiwan 12 898 2.0× 208 1.1× 96 0.5× 276 1.6× 90 0.6× 18 1.4k
Tielong Chen China 13 613 1.4× 149 0.8× 140 0.7× 339 2.0× 183 1.3× 43 1.1k

Countries citing papers authored by Naibin Yang

Since Specialization
Citations

This map shows the geographic impact of Naibin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naibin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naibin Yang more than expected).

Fields of papers citing papers by Naibin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naibin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naibin Yang. The network helps show where Naibin Yang may publish in the future.

Co-authorship network of co-authors of Naibin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Naibin Yang. A scholar is included among the top collaborators of Naibin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naibin Yang. Naibin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xin, et al.. (2025). Antimicrobial effect and mechanism of Sargassum carpophyllum extract against fish spoilage Pseudomonas sp. CL2. Food Bioscience. 71. 107041–107041. 2 indexed citations
2.
Wang, Aili, et al.. (2024). The association between atherogenic index of plasma and metabolic dysfunction-associated fatty liver disease as detected by FibroScan. Nutrición Hospitalaria. 41(2). 384–392. 2 indexed citations
3.
Xu, Miao, et al.. (2024). Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation. Revista da Associação Médica Brasileira. 70(3). e20230963–e20230963. 1 indexed citations
4.
Chen, Hong, Ke Xu, Lu Chen, et al.. (2024). High normal alanine aminotransferase is an indicator for better response to antiviral therapy in chronic hepatitis B. Frontiers in Immunology. 15. 1367265–1367265. 1 indexed citations
5.
Shi, Guang‐Xia, Chunmei Jiang, Xi Yang, et al.. (2024). Prevalence of steatotic liver disease (MASLD, MetALD, ALD) and clinically significant fibrosis in US adolescents. Scientific Reports. 14(1). 25724–25724. 3 indexed citations
6.
Zhang, Shengguo, et al.. (2023). Association between body roundness index and non‐alcoholic fatty liver disease detected by Fibroscan in America. Journal of Clinical Laboratory Analysis. 37(19-20). e24973–e24973. 11 indexed citations
7.
Huang, Jiajia, Ying Liu, Yingying Zhang, et al.. (2023). Role of the extracellular matrix in COVID-19. World Journal of Clinical Cases. 11(1). 73–83. 20 indexed citations
8.
Wang, Liping, et al.. (2022). Serum uric acid to creatinine ratio is associated with higher prevalence of NAFLD detected by FibroScan in the United States. Journal of Clinical Laboratory Analysis. 36(8). e24590–e24590. 10 indexed citations
9.
Yang, Yanyan, Shanshan Li, Xueting Xie, et al.. (2022). Changes and Clinical Significance of PIVKA-II in Hepatitis E Patients. Frontiers in Public Health. 9. 784718–784718. 4 indexed citations
10.
11.
12.
Yan, Danying, Jiajia Huang, Naibin Yang, et al.. (2022). The clinical application of metagenomic next-generation sequencing in infectious diseases at a tertiary hospital in China. Frontiers in Cellular and Infection Microbiology. 12. 957073–957073. 5 indexed citations
13.
Yang, Naibin, et al.. (2021). Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Disseminated Tuberculosis of an Immunocompetent Patient. Frontiers in Medicine. 8. 687984–687984. 7 indexed citations
14.
Yang, Naibin, et al.. (2021). Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient. Frontiers in Medicine. 8. 656194–656194. 5 indexed citations
15.
Qian, Guoqing, Naibin Yang, Feng Ding, et al.. (2020). Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM. 113(7). 474–481. 298 indexed citations
16.
Qian, Guoqing, Naibin Yang, Ada Ma, et al.. (2020). COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China. Clinical Infectious Diseases. 71(15). 861–862. 207 indexed citations
17.
18.
19.
Hu, Danping, et al.. (2017). miR-203 inhibits the expression of collagen-related genes and the proliferation of hepatic stellate cells through a SMAD3-dependent mechanism. Molecular Medicine Reports. 16(2). 1248–1254. 11 indexed citations
20.
Yang, Naibin, et al.. (2015). Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.. PubMed. 8(8). 9062–71. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junke Long Breakdown of academic impact, for papers by Mingxing Huang Breakdown of academic impact, for papers by Kamran Baig Breakdown of academic impact, for papers by Haibin Wang Breakdown of academic impact, for papers by Zhen Chen Breakdown of academic impact, for papers by Fangqiang Wei Breakdown of academic impact, for papers by Yi‐Chang Cheng Breakdown of academic impact, for papers by Tielong Chen
Rankless by CCL
2026